The Oncology Institute · 2 months ago
Hematologist Oncologist Hemet, CA
Hemet, California, United States
Full-time
Onsite
Senior Level
$600K/yr - $650K/yrThe Oncology Institute is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. As a TOI Physician, you will provide support to patients throughout their care journey while having opportunities for leadership and collaboration within a dedicated team.
Health CareHealth DiagnosticsHome Health CareMedicalOncologyPsychology
Responsibilities
Make a difference in the lives of our patients while building relationships and providing support throughout their care journey
Grow as a leader, whether pursuing a role as a Medical Director or Principal Investigator within Clinical Research
Work within community centered clinics while having access to Medical Director and extended Physician leadership team for support, collaboration, and guidance
Participate in Tumor Boards, case discussions, and on-going professional education with a collaborative Physician team and within the community
Qualification
Required
Board Certified/Board Eligible in Hematology and Oncology
Eligible for medical licensure in California
H1B candidates considered and welcome to apply
Benefits
Sign On Bonus
Relocation Assistance
Student Loan Repayment Assistance
Company
The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting.
Founded in 2007
501-1000 employees
H1B Sponsorship
The Oncology Institute has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (1)
Funding
Current Stage
Public CompanyTotal Funding
$291.5MKey Investors
Deerfield
2025-03-24Post Ipo Equity· $16.5M
2021-11-15Post Ipo Equity· $275M
2021-11-15IPO
Leadership Team
Daniel Virnich
Board Member
Jeffrey Langsam
Chief Clinical Officer
Recent News
2026-01-11
2026-01-10
2026-01-05
Company data provided by crunchbase